Jinling Pharmaceutical Company Limited (000919.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Jinling Pharmaceutical Company Limited
—
Jinling Pharmaceutical Company Limited is led by CEO Hai Chen, employs 5,716 people, headquartered in Nanjing, CN, publicly traded since 1999.
Jinling Pharmaceutical Company Limited (000919.SZ) stock trades at $6.14 with a market capitalization of $4.02B. The stock is valued at a price-to-earnings (P/E) ratio of 71.78, price-to-book of 1.07, price-to-sales of 1.26. Over the past 52 weeks the stock has ranged between $5.67 and $9.80, and currently trades 37.3% below its 52-week high. It pays a dividend yielding 1.55%.
On profitability, Jinling Pharmaceutical Company Limited generates a return on equity (ROE) of 1.18%, an operating margin of 4.68%, a net profit margin of 1.76%.
Official website: jlyy1999.com
Jinling Pharmaceutical Company Limited (000919.SZ) — frequently asked questions
What is Jinling Pharmaceutical Company Limited (000919.SZ) stock price today?
Jinling Pharmaceutical Company Limited (000919.SZ) is currently trading at $6.14, down 1.76% today.
What is 000919.SZ P/E ratio?
Jinling Pharmaceutical Company Limited's P/E ratio is 71.78. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 000919.SZ return on equity (ROE)?
Jinling Pharmaceutical Company Limited's return on equity (ROE) is 1.18%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Jinling Pharmaceutical Company Limited's market cap?
Jinling Pharmaceutical Company Limited has a market capitalization of $4.02B.
Does 000919.SZ pay a dividend?
Yes. Jinling Pharmaceutical Company Limited currently yields 1.55%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 000919.SZ carry?
Jinling Pharmaceutical Company Limited has a debt-to-equity ratio of 0.04. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 000919.SZ's profit margin?
Jinling Pharmaceutical Company Limited reports a net profit margin of 1.76% — the share of revenue left after every cost, including tax and interest.
What sector is 000919.SZ in?
Jinling Pharmaceutical Company Limited is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 000919.SZ listed on?
Jinling Pharmaceutical Company Limited trades on SHZ under the ticker 000919.SZ.
What is 000919.SZ's 52-week range?
Over the last year Jinling Pharmaceutical Company Limited has traded between $5.67 and $9.80.
Related — Stocks
Popular Stocks
Screens 000919.SZ currently matches
On the figures above, Jinling Pharmaceutical Company Limited passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.